Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB3 | P13945 | 15/20 | 0.74 |
| ▸ | ADRB1 | P08588 | 14/20 | 0.74 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.52 |
| ▸ | MEN1 | O00255 | 4/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.48 |
| ▸ | RXFP1 | Q9HBX9 | 2/20 | 0.48 |
| ▸ | NPC1 | O15118 | 1/20 | 0.48 |
| ▸ | RAB9A | P51151 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6538446 | 0.94 | ADRB3 (0.80) | ADRB3ADRB1ADRB2NPC1RAB9A | |
| SCHEMBL7531125 | 0.93 | ADRB3 (0.86) | ADRB3ADRB1ADRB2MEN1KMT2A | |
| SCHEMBL6539456 | 0.91 | ADRB3 (0.73) | ADRB3ADRB1ADRB2MEN1KMT2A | |
| SCHEMBL6538957 | 0.91 | ADRB3 (0.73) | ADRB3ADRB1ADRB2MEN1KMT2A | |
| SCHEMBL6538706 | 0.91 | ADRB3 (0.73) | ADRB3ADRB1ADRB2MEN1KMT2A | |
| SCHEMBL7039822 | 0.91 | ADRB3 (0.74) | ADRB3ADRB1ADRB2MEN1KMT2A | |
| SCHEMBL6538700 | 0.90 | ADRB3 (0.72) | ADRB3ADRB1ADRB2MEN1KMT2A | |
| SCHEMBL6539083 | 0.90 | ADRB3 (0.84) | ADRB3ADRB1ADRB2NPC1RAB9A | |
| SCHEMBL6539053 | 0.89 | ADRB3 (0.69) | ADRB3ADRB1ADRB2MEN1KMT2A | |
| SCHEMBL6539609 | 0.89 | ADRB3 (0.72) | ADRB3ADRB1ADRB2NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6826033-B2 | BETA 3 ADRENERGIC RECEPTOR AGONISTS; TREATMENT OF POLLAKIURIA, URINARY INCONTINENCE, OBESITY OR DIABETES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2004-11-30 | — | — | US | disclosed |
| US-20040037022-A1 | Aminoalcohol derivatives | ASTELLAS PHARMA INC. (JP) | 2004-02-26 | — | — | US | disclosed |
| WO-2002024635-A2 | AMINOALCOHOL DERIVATIVES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2002-03-28 | — | — | WO | disclosed |